- Home
- ALLR vs DLXY Comparison
ALLR vs DLXY Comparison
Compare ALLR & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLR | DLXY |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 13.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | ALLR | DLXY |
|---|---|---|
| Price | $1.18 | $0.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 138.7K | 67.3K |
| Earning Date | 11-14-2025 | 12-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1077.13 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $273,155,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $0.61 |
| 52 Week High | $2.35 | $7.16 |
Technical Indicators
Market Signals| Indicator | ALLR | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 55.05 | N/A |
| Support Level | $1.09 | N/A |
| Resistance Level | $1.23 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 81.07 | 0.00 |
Price Performance
Historical ComparisonAbout ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About DLXY Delixy Holdings Limited Ordinary Shares
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.